New drug duo tested for tough cancers
Disease control
Terminated
This early-stage study tested a combination of two drugs (JS004 and Toripalimab) in 31 adults with advanced solid tumors like liver, esophageal, and stomach cancers that had stopped responding to standard treatments. The main goal was to check safety and side effects. The study w…
Phase: PHASE1 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 03:13 UTC